chemical maker’s stock faces headwinds, sees potential By Investing.com
Celanese (NYSE:) Corporation, a global chemical and specialty materials company currently valued at $7.25 billion, has faced significant challenges in recent quarters, leading to a mixed outlook from analysts. The company’s stock has declined nearly 50% over the past six months, now trading near its 52-week low of $65.50. Despite these headwinds, InvestingPro analysis suggests the stock is currently undervalued, though the company has grappled with weak demand in key end markets, operational issues, and concerns over its leverage following a major acquisition. However, some analysts see potential for a recovery in the coming years as the company implements cost-cutting measures and awaits an upturn in its cyclical markets.
